Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.

by Hassan Nehme, Patrick Saulnier, Alyaa A Ramadan, Viviane Cassisa, Catherine Guillet, Matthieu Eveillard, Anita Umerska
Published 2018-01-01

Topical cyclosporine A for the treatment of dry eye: a randomized clinical study

by Injy Y ElShazly, Mahmoud H Morsy, Adnan A Bekhit, Alyaa A Ramadan, Ehab F Mossallam
Published 2021-01-01

Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits

by Lubna M. Eldesouky, Riham M. El-Moslemany, Alyaa A. Ramadan, Mahmoud H. Morsi, Nawal M. Khalafallah
Published 2021-03-01

Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules

by Nabila A. El-Sheridy, Riham M. El-Moslemany, Alyaa A. Ramadan, Maged W. Helmy, Labiba K. El-Khordagui
Published 2021-01-01

Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

by Maha M Eissa, Riham M El-Moslemany, Alyaa A Ramadan, Eglal I Amer, Mervat Z El-Azzouni, Labiba K El-Khordagui
Published 2015-01-01